D-CON 10-Oct 2.5/5;MG

The Brand Name D-CON Has Generic Salt :: Glibenclamide 

D-CON  Is From Company GRANDIX Priced :: Rs. 2.80/6.40

D-CON have Glibenclamide is comes under Sub class #N/A of  Main Class #N/A

Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Glibenclamide  TAB  Rs. 2.80/6.40  10-Oct
Brand Name Company / Manufacturers Strength Unit Price / 10-Oct
 D-CON  GRANDIX  2.5/5;MG  10-Oct Rs. 2.80/6.40

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From GRANDIX :: D-CON  Glibenclamide  #N/A #N/A

Indications for Drugs ::

Type 2 DM

Drug Dose ::

Adult: PO Initial: 2.5-5 mg/day, up to 15 mg/day. Max: 20 mg/day.

Contraindication ::

Severe or life-threatening hyperglycaemia, severe liver or renal failure, type 1 diabetes, diabetic ketoacidosis with or without coma, patients with severe infection or trauma.

Drug Precautions ::

Elderly; malnourished; mild to moderate renal and hepatic disorders. Impaired alertness. Avoid alcohol. Careful monitoring of blood-glucose concentration. Adrenocortical insufficiency. Changes in diet or prolonged exercise may also provoke hypoglycaemia. Increased risk of hypoglcaemia due to its long half-life. Avoid in severe hepatic impairment. Pregnancy, lactation.

Drug Side Effects ::

Hypoglycaemia; cholestatic jaundice; agranulocytosis; aplastic anaemia; haemolytic anaemia. Blood dyscrasias (reversible), liver dysfunction, hypoglycaemia, GI symptoms, allergic skin reactions. Potentially Fatal: Prolonged hypoglycaemia seen in elderly or debilitated patients with hepatic or renal diseases.

Pregnancy category ::
Pregnancy category

3

Drug Mode of Action ::  

Glibenclamide lowers blood glucose concentration principally by stimulating secretion of endogenous insulin from the pancreatic ?-cells. Hypoglycaemic action associated w/ short-term therapy appears to include reduction of basal hepatic glucose production and enhancement of peripheral insulin action at target sites.

Drug Interactions ::

Serum levels may be reduced by colesevelam. May increase hypoglycaemic effect w/ MAOIs, chloramphenicol, fluoroquinolones (e.g. ciprofloxacin), probenecid, NSAIDs, ACE inhibitors, fluoxetine, disopyramide, clarithromycin, salicylates, sulfonamides, ?-blockers. Increased serum levels w/ antifungal antibiotics (e.g. miconazole, fluconazole). May decrease hypoglycaemic effect w/ nonthiazide (e.g. furosemide) and thiazide diuretics, corticosteroids, phenothiazines, thyroid agents, oestrogens, OC, phenytoin, nicotinic acid, sympathomimetic agents, rifampicin, Ca channel blockers, isoniazid. Potentially Fatal: May increase hepatotoxic effect of bosentan.

 

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Related Posts:
You May Also Like::
Tagged with